← Leaderboards
Norman Edward Sharpless
University Of North Carolina Chapel Hill
$12,085,254
Attributed
$14,111,768
Total exposure
10
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $11.4M · FY2005–16$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$37,616,490 · 11
By mechanism
P30$25,520,713 · 4
R01$7,402,947 · 4
P01$2,046,680 · 1
K12$1,986,961 · 1
K08$659,189 · 1
Top collaborators
- Kwok Kin Wong5 shared
- Charles M Perou3 shared
- Amanda Elam1 shared
- Natalia Mitin1 shared
- Hyman B Muss1 shared
Most similar at University Of North Carolina Chapel Hill
Same institution · by research overlap
- Jo Anne L Earp$6,192,804
- Elizabeth C Dees$8,557,163
- Joseph S Pagano$26,597,625
- Albert Sidney Baldwin$25,224,800
- Blossom A Damania$35,988,246
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsAreaAnticancer ResearchMolecularFundingTranslational ResearchBasic ScienceProgramsNorth CarolinaFacultyEventResearch PersonnelMemberTrainingResistanceUniversitiesGeneticCancer TherapyPopulation SciencesClinical SciencesNeoplasm MetastasisCancer CenterLeadershipCdkn2a Gene
Grant awards (58)
Cancer Center Support Grant$7,160,362
P30 · FY2016 · CA · contact PI
ADMINISTRATION (Admin Core)$1,008,454
P30 · FY2016 · CA · contact PI
DEVELOPMENTAL FUNDS (Core 002)$953,077
P30 · FY2016 · CA · contact PI
Biomarkers of Molecular Age to Predict the Toxicity of Cancer Chemotherapy$572,222
R01 · FY2016 · CA · contact PI
(PQD5) Predicting Anti-Cancer Efficacy through Tumor Profiling$405,890
R01 · FY2016 · CA · contact PI
In vivo murine models of metastasis for therapeutic testing$400,209
R01 · FY2016 · CA · contact PI
The Role of p16INK4 in Mammalian Aging$335,160
R01 · FY2016 · AG · contact PI
Cancer Center Support Grant$140,249
P30 · FY2016 · CA · contact PI
Cancer Center Support Grant$125,000
P30 · FY2016 · CA · contact PI
Cancer Center Support Grant$116,771
P30 · FY2016 · CA · contact PI
Cancer Center Support Grant$76,560
P30 · FY2016 · CA · contact PI
PLANNING AND EVALUATION (Core 001)$54,460
P30 · FY2016 · CA · contact PI
Cancer Center Support Grant$35,513
P30 · FY2016 · CA · contact PI
Cancer Center Core Support Grant$6,790,080
P30 · FY2015 · CA · contact PI
Cancer Center Core Support Grant$1,009,128
P30 · FY2015 · CA · contact PI
(PQD5) Predicting Anti-Cancer Efficacy through Tumor Profiling$405,890
R01 · FY2015 · CA · contact PI
In vivo murine models of metastasis for therapeutic testing$400,209
R01 · FY2015 · CA · contact PI
The Role of p16INK4 in Mammalian Aging$335,160
R01 · FY2015 · AG · contact PI
UNC Oncology Clinical Translational Research Training Program$135,139
K12 · FY2015 · CA · contact PI
Cancer Center Core Support Grant$62,499
P30 · FY2015 · CA · contact PI
Cancer Center Core Support Grant$59,750
P30 · FY2015 · CA · contact PI
Cancer Center Core Support Grant$47,351
P30 · FY2015 · CA · contact PI
Cancer Center Core Support Grant$31,250
P30 · FY2015 · CA · contact PI
Cancer Center Core Support Grant$6,597,984
P30 · FY2014 · CA · contact PI
Cigarette Warning Labels: Research Synthesis and Impact on Smoking Behavior$1,015,491
P30 · FY2014 · CA · contact PI
UNC Oncology Clinical Translational Research Training Program$438,740
K12 · FY2014 · CA · contact PI
(PQD5) Predicting Anti-Cancer Efficacy through Tumor Profiling$405,890
R01 · FY2014 · CA · contact PI
In vivo murine models of metastasis for therapeutic testing$388,202
R01 · FY2014 · CA · contact PI
Cancer Center Core Support Grant$149,896
P30 · FY2014 · CA · contact PI
The Role of p16INK4a in Mammalian Aging$100,000
R01 · FY2014 · AG · contact PI
Cancer Center Core Support Grant$75,000
P30 · FY2014 · CA · contact PI
Cancer Center Core Support Grant$11,838
P30 · FY2014 · CA · contact PI
UNC Oncology Clinical Translational Research Training Program$570,391
K12 · FY2013 · CA · contact PI
In vivo murine models of metastasis for therapeutic testing$376,196
R01 · FY2013 · CA · contact PI
The Role of p16INK4a in Mammalian Aging$272,833
R01 · FY2013 · AG · contact PI
UNC Oncology Clinical Translational Research Training Program$574,664
K12 · FY2012 · CA · contact PI
In vivo murine models of metastasis for therapeutic testing$412,209
R01 · FY2012 · CA · contact PI
The Role of p16INK4a in Mammalian Aging$288,712
R01 · FY2012 · AG · contact PI
Murine & Human In Vivo Models of Melanoma Formation$426,041
P01 · FY2011 · ES · contact PI
The Role of p16INK4a in Mammalian Aging$288,712
R01 · FY2011 · AG · contact PI
UNC Oncology Clinical Translational Research Training Program$268,027
K12 · FY2011 · CA · contact PI
Murine & Human In Vivo Models of Melanoma Formation$436,825
P01 · FY2010 · ES · contact PI
The Role of p16INK4a in Mammalian Aging$300,366
R01 · FY2010 · AG · contact PI
Murine & Human In Vivo Models of Melanoma Formation$434,463
P01 · FY2009 · ES · contact PI
The Role of p16INK4a in Mammalian Aging$303,400
R01 · FY2009 · AG · contact PI
Murine & Human In Vivo Models of Melanoma Formation$415,642
P01 · FY2008 · ES · contact PI
The role of p16INK4a in mammalian aging$270,249
R01 · FY2008 · AG · contact PI
Murine & Human In Vivo Models of Melanoma Formation$333,709
P01 · FY2007 · ES · contact PI
The role of p16INK4a in mammalian aging$275,765
R01 · FY2007 · AG · contact PI
The role of p16INK4a in mammalian aging$284,001
R01 · FY2006 · AG · contact PI
Melanoma in p16INK4a and p19ARF Deficient Mice$130,918
K08 · FY2006 · CA · contact PI
The role of p16INK4a in mammalian aging$290,836
R01 · FY2005 · AG
Melanoma in p16INK4a and p19ARF Deficient Mice$130,918
K08 · FY2005 · CA
The role of p16INK4a in mammalian aging$290,836
R01 · FY2004 · AG
Melanoma in p16INK4a and p19ARF Deficient Mice$130,918
K08 · FY2004 · CA
Melanoma in p16INK4a and p19ARF Deficient Mice$130,918
K08 · FY2003 · CA
Melanoma in p16INK4a and p19ARF Deficient Mice$104,504
K08 · FY2002 · CA
Melanoma in p16INK4a and p19ARF Deficient Mice$31,013
K08 · FY2002 · CA